➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Moodys
Colorcon
Dow

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 8,937,048

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,937,048
Title:Anti-angiogenic compounds
Abstract: The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules.
Inventor(s): Doppalapudi; Venkata Ramana (San Diego, CA), Lai; Jing-Yu (San Diego, CA), Liu; Bin (San Diego, CA), Liu; Dingguo (San Marcos, CA), Desharnais; Joel (La Mesa, CA), Bhat; Abhijit Suresh (Encinitas, CA), Fu; Yanwen (San Diego, CA), Oates; Bryan Douglas (Carlsbad, CA), Chen; Gang (San Diego, CA), Bradshaw; Curt William (San Diego, CA)
Assignee: Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE)
Application Number:13/595,250
Patent Claims:see list of patent claims

Details for Patent 8,937,048

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX Orphan search
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin VIAL;SINGLE-DOSE 761060 001 2018-04-09   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Covx Technologies Ireland, Limited (Dun Laoighaire County Dublin, IE) 2039-02-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Dow
AstraZeneca
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.